Time to treatment failure and overall survival for triple-negative subgroup, by race
Taken from "Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342"
Breast Cancer Research 2006;8(6):R66-R66.
Published online 27 Nov 2006
PMCID:PMC1797029.Time to treatment failure: not triple negative and triple negative. Overall survival: not triple negative and triple negative. Patients were classified by race (African-American [dashed line] or Caucasian [solid line]) and divided into subsets based on triple-negative status. Exploratory analysis to investigate the interaction of triple negative status and race.